Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ludwig Knabl

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Microbial Cell Factories|January 5, 2022
Xanthoepocin, a photolabile antibiotic of Penicillium ochrochloron CBS 123823 with high activity against multiresistant gram-positive bacteriaPamela Vrabl, Bianka Siewert, Jacqueline Winkler, et al.
Epidemiology and Infection|February 18, 2021
Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, AustriaJens Lehmann, Johannes M Giesinger, Gerhard Rumpold, et al.
Rheumatology (Oxford, England)|April 17, 2026
A rare JAK2 mutation associated with adult-onset Still's disease and exacerbated vaccine-induced innate immune responseHye Kyung Lee, Sivahari Prasad Gorantla, Teemu Haikarainen, et al.
Nature Communications|December 13, 2022
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 6, 2021
A high leukocyte count and administration of hydrocortisone hamper PCR-based diagnostics for bloodstream infectionsSilke Huber, Johannes Weinberger, Matthias Pilecky, et al.
NPJ Vaccines|May 18, 2024
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster seraAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Microorganisms|April 27, 2024
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 VariantsChristoph Schatz, Ludwig Knabl, Hye Kyung Lee, et al.
NPJ Vaccines|July 1, 2026
Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster seraMarta Bermejo-Jambrina, Antonia Netzl, Ludwig Knabl, et al.
Vaccine|July 5, 2025
Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patternsMelanie M Schmitt, Annika Rössler, Antonia Netzl, et al.
International Journal of Medical Microbiology : IJMM|August 2, 2018
Shiga toxin 2a binds antithrombin and heparin, but does not directly activate plateletsLudwig Knabl, Michael Berktold, Osama A Hamad, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Microbial Cell Factories|January 5, 2022
Xanthoepocin, a photolabile antibiotic of Penicillium ochrochloron CBS 123823 with high activity against multiresistant gram-positive bacteriaPamela Vrabl, Bianka Siewert, Jacqueline Winkler, et al.
Epidemiology and Infection|February 18, 2021
Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, AustriaJens Lehmann, Johannes M Giesinger, Gerhard Rumpold, et al.
Rheumatology (Oxford, England)|April 17, 2026
A rare JAK2 mutation associated with adult-onset Still's disease and exacerbated vaccine-induced innate immune responseHye Kyung Lee, Sivahari Prasad Gorantla, Teemu Haikarainen, et al.
Nature Communications|December 13, 2022
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 6, 2021
A high leukocyte count and administration of hydrocortisone hamper PCR-based diagnostics for bloodstream infectionsSilke Huber, Johannes Weinberger, Matthias Pilecky, et al.
NPJ Vaccines|May 18, 2024
Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster seraAnnika Rössler, Antonia Netzl, Ludwig Knabl, et al.
Microorganisms|April 27, 2024
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 VariantsChristoph Schatz, Ludwig Knabl, Hye Kyung Lee, et al.
NPJ Vaccines|July 1, 2026
Mapping SARS-CoV-2 immunity after an XBB.1.5 booster by antigenic cartography of merged human and hamster seraMarta Bermejo-Jambrina, Antonia Netzl, Ludwig Knabl, et al.
Vaccine|July 5, 2025
Exposure to two antigenically distinct SARS-CoV-2 variants broadens neutralization patternsMelanie M Schmitt, Annika Rössler, Antonia Netzl, et al.
International Journal of Medical Microbiology : IJMM|August 2, 2018
Shiga toxin 2a binds antithrombin and heparin, but does not directly activate plateletsLudwig Knabl, Michael Berktold, Osama A Hamad, et al.
Pageof 6